申请人:SCHERING AKTIENGESELLSCHAFT
公开号:EP0358284A2
公开(公告)日:1990-03-14
Novel derivatized alkanolamines of the following structural formula
are described as useful cardiovascular agents. Most especially described is their usefulness as cardiovascular agents exhibiting an antiarrhythmic effect. Said antiarrhythmic effect is of a combination Class II/Class III variety. Pharmaceutical formulations containing such compounds are also described.
结构式如下的新型衍生化烷醇胺
被描述为有用的心血管制剂。尤其是它们作为心血管药剂具有抗心律失常的作用。所述抗心律失常作用为 II 类/III 类联合作用。还描述了含有此类化合物的药物制剂。